Average Co-Inventor Count = 4.59
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (19 from 1,149 patents)
2. Smithkline Beecham Corporation (10 from 2,198 patents)
3. Novartis Ag (4 from 3,923 patents)
4. Ledeboer, Mark W. (0 patent)
5. Davies, Robert J. (0 patent)
33 patents:
1. 12433949 - Sustained release delivery systems comprising traceless linkers
2. 11389541 - Sustained delivery of angiopoetin-like 3 polypeptides
3. 10751417 - Sustained release delivery systems comprising traceless linkers
4. 8741912 - Deazapurines useful as inhibitors of Janus kinases
5. 8703761 - Organic compounds
6. 8691848 - Inhibitors of caspases
7. 8524720 - Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful as protein kinase inhibitors
8. 7902239 - Diaminotriazoles useful as inhibitors of protein kinases
9. 7872129 - Compositions useful as inhibitors of GSK-3
10. 7691853 - Pyrazole compounds useful as protein kinase inhibitors
11. 7645775 - Triazoles useful as inhibitors of protein kinases
12. 7598245 - Aminotriazole compounds useful as inhibitors of protein kinases
13. 7491730 - Compositions useful as inhibitors of GSK-3
14. 7390815 - Pyrazole compounds useful as protein kinase inhibitors
15. 7358273 - Inhibitors of caspases